Baltera Robert Jr. 4
4 · Frazier Lifesciences Acquisition Corp · Filed Nov 23, 2022
Insider Transaction Report
Form 4
Baltera Robert Jr.
Director
Transactions
- Exercise/Conversion
Class B Ordinary Shares
2022-11-22−30,000→ 0 total→ Class A Ordinary Shares (30,000 underlying)
Footnotes (1)
- [F1]Pursuant to the terms outlined in the Business Combination Agreement, dated July 25, 2022, by and among NewAmsterdam Pharma Holding B.V., Frazier Lifesciences Acquisition Corporation, NewAmsterdam Pharma Investment Corporation, and NewAmsterdam Pharma Company B.V., these shares were automatically converted into Class A ordinary shares of NewAmsterdam Pharma Company N.V. (Nasdaq symbol "NAMS"). The Business Combination closed on November 22, 2022.